the ability of leukemic cells to phosphorylate cytosine arabinoside ( arac ) and retain the triphosphate form of the drug ( aractp ) is strongly predictive of remission duration for patients with acute nonlymphocytic leukemia who are treated with arac-based maintenance therapy .
C1517806
leukemic cells
C0023467
acute nonlymphocytic leukemia